Pelopac S.A.
FDA import alert and refusal historySindos, GreeceFEI 3005607884
As of October 27, 2026, Pelopac S.A. has no FDA import alert listing or import refusal in SupplierRadar's records; its most recent FDA inspection, on March 27, 2024, was classified NAI (No Action Indicated).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- Classified NAI (No Action Indicated)
Every FDA record for Pelopac S.A.
3 records, newest first. Each line links to the FDA page it came from.
2024
- InspectionInspection classified NAI (No Action Indicated)Food Composition, Standards, Labeling and Econ; Foodborne Biological HazardsSource
2019
- InspectionInspection classified NAI (No Action Indicated)Food Composition, Standards, Labeling and Econ; Foodborne Biological HazardsSource
2012
- InspectionInspection classified NAI (No Action Indicated)Foodborne Biological HazardsSource
Questions about Pelopac S.A.
- Is Pelopac S.A. on an FDA import alert?
- No listing for Pelopac S.A. appears in the FDA import alerts SupplierRadar checked on October 27, 2026. Country-wide alerts may still apply to its products; see the Greece page.
- Has FDA refused shipments from Pelopac S.A.?
- No FDA import refusals for Pelopac S.A. appear in FDA's refusal data since October 2016, as of October 27, 2026.
- When was Pelopac S.A. last inspected by FDA?
- FDA's most recent inspection of Pelopac S.A. with a final classification is dated March 27, 2024 and was classified NAI (No Action Indicated).
- What is Pelopac S.A.'s FEI number?
- Pelopac S.A.'s FDA Establishment Identifier (FEI) is 3005607884.
Buying from Pelopac S.A.?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.